Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a free radical scavenger that has shown potent antioxidant, anti-inflammatory and neuroprotective effects in variety of disease models. In this study ...

New Delhi, Gland Pharma Ltd on Tuesday said it has received approval from the US health regulator for its generic Edaravone injection to treat amyotrophic lateral sclerosis. The approval by the US ...

Gland Pharma Ltd’s shares were up after the company received approval from the United States Food and Drug Administration (USFDA) for two products, Edaravone Injection and Plerixafor Injection.

Long-term add-on treatment with intravenous (IV) edaravone is not associated with any change in the progression of amyotrophic lateral sclerosis (ALS), new research shows. These findings contradict ...

Edaravone injection is used to treat amyotrophic lateral sclerosis (ALS). (Image Credits: Pixabay) Gland Pharma Ltd on Tuesday announced that it has received approval from the US health regulator for ...

The medicine for patients with Amyotrophic Lateral Sclerosis (ALS) was unveiled in the form of Edaravone injection vials by a knowledge-based company in the Growth Center of Iran University of Medical ...

Background Studies have shown that ischemia-reperfusion (I/R) produces free radicals leading to lipid peroxidation and damage to skeletal muscle. The purposes of this study were 1) to assess the ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Edaravone (Aravon) is prescribed for treating ...

Gland Pharma Ltd announced on Tuesday that it has obtained approval from the US Food and Drug Administration (USFDA) for its generic Edaravone injection used in treating amyotrophic lateral sclerosis ...